Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled study of VC005 tablets in active ankylosing spondylitis
CTR20253546Phase 3Active
- Sponsor
- Wecare Probiotics
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of VC-005 in ankylosing spondylitis (AS), sponsored by Wecare Probiotics. Started Dec 2025; status: active.
02
Drugs
VC-005
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on CTR20253546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253546.